How I investigate acquired megaloblastic anemia

被引:21
作者
Torrez, Mary [1 ]
Chabot-Richards, Devon [1 ]
Babu, Daniel [1 ]
Lockhart, Evelyn [1 ]
Foucar, Kathryn [1 ]
机构
[1] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA
关键词
anemia; B12; bone marrow; Folate; hematopoiesis; RBC; VITAMIN-B-12; DEFICIENCY; PERNICIOUS-ANEMIA; COBALAMIN DEFICIENCY; FOLATE-DEFICIENCY; PARIETAL-CELL; DIAGNOSIS; HOLOTRANSCOBALAMIN; ANTIBODIES; PATIENT;
D O I
10.1111/ijlh.13789
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this review of megaloblastic anemia (MA), an overview of vitamin B-12 and folate body requirements, biochemical pathways, and laboratory testing strategies will be provided. However, the focus of this review is the classic and unique features of MA in blood and bone marrow. Acquired MA is a benign disorder for many, but can be detrimental for some. The clinical presentation can vary considerably, and the spectrum of symptoms and signs is diverse and quite broad. Prompt recognition and therapy are critical to prevent potential irreversible damage and clinical sequelae, especially in patients with vitamin B-12 deficiency. A delay in diagnosis of vitamin B-12 deficiency can result in significant neurologic sequelae that may not fully resolve with treatment, including in neonates and young infants. The blood and bone marrow features in MA can closely mimic thrombocytopenic purpura, myelodysplasia, and other myeloid neoplasms. Both pancytopenia and normal MCV at presentation are common in MA and raise unique challenges for the diagnostician. Partially treated MA is also a significant diagnostic "trap". MA is highly responsive to treatment, and patients tend to improve rapidly upon treatment initiation. However, the broad range of clinical and hematologic features makes the rapid, successful diagnosis of MA a unique challenge for the hematopathologist. Even in the era of state-of-the-art laboratory testing, a high suspicion is required.
引用
收藏
页码:236 / 247
页数:12
相关论文
共 55 条
[41]   Laboratory testing for cobalamin deficiency in megaloblastic anemia [J].
Oberley, Matthew J. ;
Yang, David T. .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) :522-526
[42]   Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome [J].
Parmentier, Stefani ;
Meinel, Joern ;
Oelschlaegel, Uta ;
Mohr, Brigitte ;
Ehninger, Gerhard ;
Schaich, Markus ;
Platzbecker, Uwe .
ANNALS OF HEMATOLOGY, 2012, 91 (12) :1979-1981
[43]   Anti-parietal cell antibodies - diagnostic significance [J].
Rusak, Ewa ;
Chobot, Agata ;
Krzywicka, Agnieszka ;
Wenzlau, Janet .
ADVANCES IN MEDICAL SCIENCES, 2016, 61 (02) :175-179
[44]   Vitamin B12 deficiency and clinical laboratory: Lessons revisited and clarified in seven questions [J].
Salinas, M. ;
Flores, E. ;
Lopez-Garrigos, M. ;
Leiva-Salinas, C. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 :83-88
[45]   Schistocytosis occurs in severely anemic B12-deficient patients and does not imply thrombotic thrombocytopenic purpura [J].
Savjani, M. ;
Bhat, A. ;
Marcelino, A. ;
Luhrs, C. ;
Braverman, A. S. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (05) :E93-E94
[46]   VITAMIN-B12 ABSORPTION AND MALABSORPTION [J].
SCHJONSBY, H .
GUT, 1989, 30 (12) :1686-1691
[47]   Combined B12 and folate deficiency presenting as an aggressive hematologic malignancy [J].
Singh, Nathan ;
Qayyum, Sohail ;
Wasik, Mariusz A. ;
Luger, Selina M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) :964-965
[48]   Laboratory assessment of folate (vitamin B9) status [J].
Sobczynska-Malefora, Agata ;
Harrington, Dominic J. .
JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) :949-956
[49]   Severe megaloblastic anemia: Vitamin deficiency and other causes [J].
Socha, Daniel S. ;
DeSouza, Sherwin, I ;
Flagg, Aron ;
Sekeres, Mikkael ;
Rogers, Heesun J. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (03) :153-164
[50]  
Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]